TY - JOUR T1 - Large variation in the association between seasonal antibiotic use and resistance across multiple bacterial species and antibiotic classes JF - medRxiv DO - 10.1101/2020.12.21.20248670 SP - 2020.12.21.20248670 AU - Daphne S. Sun AU - Stephen M. Kissler AU - Sanjat Kanjilal AU - Scott W. Olesen AU - Marc Lipsitch AU - Yonatan H. Grad Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/12/22/2020.12.21.20248670.abstract N2 - Understanding how antibiotic use drives resistance is crucial for guiding effective strategies to limit the spread of resistance, but the variation in the use-resistance relationship across pathogens and antibiotics remains unclear. Here, we applied sinusoidal models to evaluate the seasonal use-resistance relationship across 3 species and 5 antibiotic classes in Boston, Massachusetts. Use of all 5 classes and resistance in 10 of 15 species-antibiotic combinations showed significant amplitudes of seasonality. However, while seasonal peaks in use varied by class, resistance in all 10 species-antibiotic combinations peaked in the winter and spring. The correlations between seasonal use and resistance thus varied widely, with resistance to all antibiotic classes being most positively correlated with use of the winter-peaking classes (penicillins and macrolides). These findings suggest that in some cases the simple model of use selecting for resistance is inadequate and stewardship strategies will not be equally effective across all species and antibiotics.Competing Interest StatementY. H. G. and M. L. have received grant support from Pfizer. The other authors declare no competing interests.Funding StatementThis work was supported by funds from the HSPH Dean's Award (to Y.H.G.) and Wellcome Trust (to Y.H.G.). D.S.S. is supported by the National Institutes of Health training grant (T32AI132120).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Mass General Brigham IRB (Protocol number: 2016P001671).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCode and data is available at: https://github.com/gradlab/use-resistance-seasonality https://github.com/gradlab/use-resistance-seasonality ER -